EAN News

SARS-CoV-2 Related Encephalitis: MRI Pattern of the Olfactory Tract Involvement

Science Denial and COVID Conspiracy Theories Potential Neurological Mechanisms and Possible Responses

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial

A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications

Delirium in Older Patients With COVID-19 Presenting to the Emergency Department

Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

EAN announces Virtual Congress in 2021

December's Executive Page is written by Elena Moro

For December 2020, we have selected the following paper: Deuschl et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017